The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
The Centers for Disease Control and Prevention says that the Federal Drug Administration has ended a program that provided ...
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 ...
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 ...
Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial.
The global pipette tips market is on the cusp of significant expansion, with forecasts indicating an impressive Compound ...
Health Canada has authorised an adapted version of the Moderna Spikevax Covid-19 vaccine which targets the original SARS-CoV-2 virus from 2019 and the Omicron (BA.1) variant. According to a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback